Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.490
0.00 (0.00%)
Feb 27, 2026, 4:00 PM EST - Market closed
Camp4 Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Camp4 Therapeutics stock have an average target of 9.00, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 100.45% from the current stock price of 4.49.
Analyst Consensus: Buy
* Price targets were last updated on Oct 2, 2025.
Analyst Ratings
The average analyst rating for Camp4 Therapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 5 | 6 | 6 | 6 | 6 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $7 | Buy | Initiates | $7 | +55.90% | Oct 2, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 16, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 → $12 | Buy | Maintains | $18 → $12 | +167.26% | Sep 15, 2025 |
| Wedbush | Wedbush | Buy Initiates $8 | Buy | Initiates | $8 | +78.17% | May 27, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
Financial Forecast
Revenue This Year
3.68M
from 652.00K
Increased by 463.96%
Revenue Next Year
2.54M
from 3.68M
Decreased by -30.92%
EPS This Year
-1.95
from -11.04
EPS Next Year
-0.94
from -1.95
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.5M | 9.2M | ||||
| Avg | 3.7M | 2.5M | ||||
| Low | 2.9M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 597.4% | 149.9% | ||||
| Avg | 464.0% | -30.9% | ||||
| Low | 350.9% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.86 | -0.83 | ||||
| Avg | -1.95 | -0.94 | ||||
| Low | -2.04 | -1.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.